---
figid: PMC11968978__41392_2025_2142_Fig1_HTML
figtitle: Canonical Wnt pathway signaling
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11968978
filename: 41392_2025_2142_Fig1_HTML.jpg
figlink: /pmc/articles/PMC11968978/figure/F1/
number: F1
caption: 'Canonical Wnt pathway signaling. Canonical Wnt pathway signaling operates
  in two distinct states: activation and inactivation. In the inactive state, the
  pathway is primarily governed by the destruction complex. Activation of the pathway
  necessitates the binding of Wnt ligands to their receptors. LRP lipoprotein receptor-related
  protein, Dvl/Dsh disheveled, GSK3β glycogen synthase kinase 3β, CK1α casein kinase
  1α, APC adenomatous polyposis coli, PP2A protein phosphatase 2 A, β-TrCP β-transduction
  repeat-containing E3 ubiquitin-protein ligase, TCF/LEF T cell factor/lymphoid enhancer
  factor, TNKS Tankyrases, CBP cyclic AMP response element-binding protein, VEGF vascular
  endothelial growth factor, EGFR epidermal growth factor receptor, SOX sex-determining
  region Y-box. Image created with BioRender (https://biorender.com/)'
papertitle: 'Wnt signaling pathways in biology and disease: mechanisms and therapeutic
  advances'
reftext: Chen Xue, et al. Signal Transduct Target Ther. 2025;10(NA).
year: '2025'
doi: 10.1038/s41392-025-02142-w
journal_title: Signal Transduction and Targeted Therapy
journal_nlm_ta: Signal Transduct Target Ther
publisher_name: Nature Publishing Group
keywords: Cancer therapy | Prognostic markers
automl_pathway: 0.9598262
figid_alias: PMC11968978__F1
figtype: Figure
redirect_from: /figures/PMC11968978__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11968978__41392_2025_2142_Fig1_HTML.html
  '@type': Dataset
  description: 'Canonical Wnt pathway signaling. Canonical Wnt pathway signaling operates
    in two distinct states: activation and inactivation. In the inactive state, the
    pathway is primarily governed by the destruction complex. Activation of the pathway
    necessitates the binding of Wnt ligands to their receptors. LRP lipoprotein receptor-related
    protein, Dvl/Dsh disheveled, GSK3β glycogen synthase kinase 3β, CK1α casein kinase
    1α, APC adenomatous polyposis coli, PP2A protein phosphatase 2 A, β-TrCP β-transduction
    repeat-containing E3 ubiquitin-protein ligase, TCF/LEF T cell factor/lymphoid
    enhancer factor, TNKS Tankyrases, CBP cyclic AMP response element-binding protein,
    VEGF vascular endothelial growth factor, EGFR epidermal growth factor receptor,
    SOX sex-determining region Y-box. Image created with BioRender (https://biorender.com/)'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ZNF3
  - RNF43
  - LRP5
  - LRP6
  - GSK3A
  - GSK3B
  - AXIN1
  - AXIN2
  - CSNK1A1
  - CTNNB1
  - APC
  - PROC
  - PTPA
  - BTRC
  - RSPO1
  - KRT10
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - IFT81
  - ADAR
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - HNF4A
  - TNKS
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - EP300
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - MYC
  - EGFR
  - SOX2
  - IL6
  - 'OFF'
  - Nucleus
---
